...
首页> 外文期刊>European journal of clinical microbiology and infectious diseases: Official publication of the European Society of Clinical Microbiology >Comparative in vitro activity of voriconazole and itraconazole against fluconazole-susceptible and fluconazole-resistant clinical isolates of Candida species from Spain.
【24h】

Comparative in vitro activity of voriconazole and itraconazole against fluconazole-susceptible and fluconazole-resistant clinical isolates of Candida species from Spain.

机译:伏立康唑和伊曲康唑对西班牙念珠菌对氟康唑敏感和耐氟康唑的临床分离株的体外活性比较。

获取原文
获取原文并翻译 | 示例
           

摘要

The in vitro activity of voriconazole was compared with that of itraconazole against 299 fluconazole-susceptible (MIC < or = 8 microg/ml) and 130 fluconazole-resistant (MIC > or = 16 microg/ml) clinical isolates of Candida spp. An adaptation of the National Committee for Clinical Laboratory Standards reference method was employed for determination of MICs. Voriconazole showed more potent activity than either fluconazole and itraconazole, even against some Candida albicans, Candida glabrata, and Candida krusei isolates resistant to fluconazole. However, for fluconazole-resistant isolates, the MICs of itraconazole and voriconazole were proportionally higher than for fluconazole-susceptible isolates. These data may indicate cross-resistance.
机译:比较了伏立康唑和伊曲康唑对299氟康唑敏感性(MIC≤8微克/毫升)和130氟康唑耐药(MIC≥16微克/毫升)念珠菌临床分离株的体外活性。国家临床实验室标准委员会参考方法的改编用于确定MIC。与氟康唑和伊曲康唑相比,伏立康唑显示出更强的活性,甚至对某些对氟康唑有抗性的白色念珠菌,光滑念珠菌和克鲁斯念珠菌也具有较强的活性。然而,对于耐氟康唑的分离株,伊曲康唑和伏立康唑的MIC均按比例高于对氟康唑敏感的分离株。这些数据可能表明交叉电阻。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号